Kidney cancer, also known as renal cell cancer, begins in the kidneys and is the common among adults and children (many children develop a specific kind of kidney cancer called Wilms' tumor). Risk of developing kidney cancer increases with age, smoking, being male, obesity, hypertension, exposure to chemicals, von hippel-lindau disease, treatment for kidney failure, and a family history. Kidney Cancer is most commonly treated with surgery, cryoablation, radiofrequency ablation, drug therapy, radiation therapy, and targeted therapy.
Stage, Kidney Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage, Kidney Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1644 products for the study of Stage, Kidney Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Stage, Kidney Cancer is also known as Renal Cell Cancer Stage, Renal Cell Carcinoma Stage.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.